sábado, 17 de diciembre de 2022

FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal | FDA

FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal | FDA

No hay comentarios:

Publicar un comentario